全文获取类型
收费全文 | 110217篇 |
免费 | 8455篇 |
国内免费 | 3392篇 |
专业分类
耳鼻咽喉 | 916篇 |
儿科学 | 2012篇 |
妇产科学 | 1137篇 |
基础医学 | 12247篇 |
口腔科学 | 2734篇 |
临床医学 | 10996篇 |
内科学 | 14346篇 |
皮肤病学 | 1651篇 |
神经病学 | 10354篇 |
特种医学 | 3831篇 |
外国民族医学 | 2篇 |
外科学 | 7848篇 |
综合类 | 18044篇 |
现状与发展 | 16篇 |
一般理论 | 4篇 |
预防医学 | 15545篇 |
眼科学 | 1658篇 |
药学 | 10519篇 |
125篇 | |
中国医学 | 4493篇 |
肿瘤学 | 3586篇 |
出版年
2024年 | 126篇 |
2023年 | 1872篇 |
2022年 | 2906篇 |
2021年 | 4621篇 |
2020年 | 4716篇 |
2019年 | 3631篇 |
2018年 | 3449篇 |
2017年 | 3507篇 |
2016年 | 3851篇 |
2015年 | 3738篇 |
2014年 | 7262篇 |
2013年 | 7706篇 |
2012年 | 6876篇 |
2011年 | 7540篇 |
2010年 | 5845篇 |
2009年 | 5555篇 |
2008年 | 5595篇 |
2007年 | 5441篇 |
2006年 | 4832篇 |
2005年 | 4191篇 |
2004年 | 3408篇 |
2003年 | 3089篇 |
2002年 | 2449篇 |
2001年 | 2228篇 |
2000年 | 1830篇 |
1999年 | 1471篇 |
1998年 | 1321篇 |
1997年 | 1213篇 |
1996年 | 961篇 |
1995年 | 1080篇 |
1994年 | 1039篇 |
1993年 | 815篇 |
1992年 | 800篇 |
1991年 | 769篇 |
1990年 | 626篇 |
1989年 | 591篇 |
1988年 | 593篇 |
1987年 | 543篇 |
1986年 | 487篇 |
1985年 | 628篇 |
1984年 | 561篇 |
1983年 | 336篇 |
1982年 | 382篇 |
1981年 | 336篇 |
1980年 | 298篇 |
1979年 | 221篇 |
1978年 | 180篇 |
1977年 | 169篇 |
1976年 | 128篇 |
1974年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
利用生物信息学技术初步探索芫根调控肠道免疫功能的分子生物学机制。方法 选择雄性SPF级BALB/c小鼠18只,随机分为3组,每组6只。SC1组小鼠每只每次灌胃芫根提取液150 μL,SC2组小鼠每只每次灌胃绞碎芫根原浆悬液150 μL,NC组小鼠每只每次灌胃生理盐水150 μL,连续7 d每日灌胃一次。分别取每组小鼠小肠组织样品提取RNA,总RNA的质检合格后,进行转录组测序。按GO功能和KEGG信号通路对差异表达基因聚类分析揭示差异表达高度富集的免疫相关通路。从免疫角度分析芫根灌胃小鼠小肠组织的基因表达变化情况。结果 转录组测序共检测到27733条 mRNA的表达,SC1组与NC组比较,显著差异表达基因1635个,其中上调差异表达基因1236个,下调差异表达基因399个;SC2组与NC组比较,显著差异表达基因2872个,其中上调差异表达基因2233个,下调差异表达基因639个(P<0.05)。按GO功能和KEGG信号通路聚类分析显示差异表达基因在白介素分泌、干扰素反应、T细胞受体信号通路及维生素和脂肪消化吸收等途径的富集度在两个芫根组中均居于前20位(P<0.01),肠黏膜趋化因子CCL20和巨噬细胞极化标志物CD274等免疫蛋白编码基因差异表达显著且同属于上述多个免疫通路。结论 芫根灌胃小鼠小肠的差异表达基因在白介素分泌、干扰素反应、T细胞受体信号通路、营养物质消化吸收等途径高度富集,提示芫根对肠道免疫系统及肠黏膜功能的调节,其中CD274的表达上调和CCL20的表达下调提示诱导M1型巨噬细胞极化和T细胞活化可能是芫根调控免疫和维护肠道正常结构功能的重要途径。 相似文献
3.
《Saudi Pharmaceutical Journal》2022,30(6):669-678
BackgroundIschemia reperfusion (I/R) play an imperative role in the expansion of cardiovascular disease. Sinomenine (SM) has been exhibited to possess antioxidant, anticancer, anti-inflammatory, antiviral and anticarcinogenic properties. The aim of the study was scrutinized the cardioprotective effect of SM against I/R injury in rat.MethodsRat were randomly divided into normal control (NC), I/R control and I/R + SM (5, 10 and 20 mg/kg), respectively. Ventricular arrhythmias, body weight and heart weight were estimated. Antioxidant, inflammatory cytokines, inflammatory mediators and plasmin system indicator were accessed.ResultsPre-treated SM group rats exhibited the reduction in the duration and incidence of ventricular fibrillation, ventricular ectopic beat (VEB) and ventricular tachycardia along with suppression of arrhythmia score during the ischemia (30 and 120 min). SM treated rats significantly (P < 0.001) altered the level of antioxidant parameters. SM treatment significantly (P < 0.001) repressed the level of creatine kinase MB (CK-MB), creatine kinase (CK) and troponin I (Tnl). SM treated rats significantly (P < 0.001) repressed the tissue factor (TF), thromboxane B2 (TXB2), plasminogen activator inhibitor 1 (PAI-1) and plasma fibrinogen (Fbg) and inflammatory cytokines and inflammatory mediators.ConclusionOur result clearly indicated that SM plays anti-arrhythmia effect in I/R injury in the rats via alteration of oxidative stress and inflammatory reaction. 相似文献
4.
5.
《台湾医志》2022,121(9):1864-1871
6.
《Transfusion Clinique et Biologique》2022,29(3):269-272
A delayed haemolytic transfusion reaction (DHTR) encompasses a positive direct antiglobulin test (DAT) developed anytime between 24 hours to 28 days after cessation of transfusion, a positive eluate or a newly identified alloantibody in the plasma or serum along with features of haemolysis in the patient. Routinely, it is expected that with the transfusion of one unit of packed red cells in a patient of average height and weight, the haemoglobin level and hematocrit increase by 1 g/dL and 3% respectively. However, in a patient with DHTR, an inadequate rise of post-transfusion haemoglobin (< 1 g/dL) or rapid fall in haemoglobin back to pre-transfusion levels is observed. Kidd antibodies are particularly known to cause DHTR, maybe alone or in unison with other antibodies. Detection of these alloantibodies is consequential in providing good transfusion support to these patients. These events may be difficult to detect as they may present as varied clinical features or immunological nuisances. In this case series, we have presented three cases of DHTR with special emphasis on their clinical presentations, immunohaematological evaluations, laboratory parameters and the role of proper transfusion support in these patients to avoid further complications. 相似文献
7.
8.
目的 探讨医院信息系统中增加住院陪护管理功能的应用效果。方法 基于互联网医院、智慧医院等信息系统,开发信息化住院陪护管理功能,包括流行病学史调查、免费核酸申请、电子陪护证办理、体温监测登记及上报和统计查询。该功能与医院智慧护理链接后全院应用。比较功能应用前和应用后的遵医嘱一患一陪达标率、有效陪护证达标率、体温监测并登记日上报达标率和陪护证使用追溯率,评价护士和管理者疫情防控管理的人均耗时以及对该管理功能的满意度。结果 应用信息化陪护管理功能后,一患一陪达标率、有效陪护证达标率、体温监测并登记日上报达标率和陪护证使用追溯率显著高于应用前(均P<0.05);护士陪护管理人均耗时从(554.13±30.77)s降至(311.67±21.54)s(P<0.05);护士和管理者对该信息化陪护管理功能的满意度显著提高(均P<0.05)。结论 信息化住院陪护管理功能的应用有效提升了疫情期间陪护的管理质量和管理效率,提高了一线护士和管理者的满意度。 相似文献
9.
《Indian journal of medical microbiology》2022,40(4):480-484
BackgroundInvasive Fungal Diseases (IFD), account for high morbidity and mortality in immunocompromised and seriously ill patients worldwide. Early, faster and accurate diagnosis with timely and appropriate patient management is critical for improved patient outcome and antifungal stewardship. Clinical/radiological presentations in IFD are non-specific and microscopy/culture based tests have low sensitivity and long turnaround time. Biomarkers have clinical utility for diagnosing IFD but their interpretation is not straight forward.ObjectivesThis review discusses the salient characteristics, clinical usefulness and limitations of common biomarkers such as Galactomannan (GM), 1–3, β D glucan (βDG), mannan, anti-mannan antibody (Mn/antiMn), Cryptococcal antigen test (CrAg), Nucleic Acid Amplification (NAA) tests and next generation sequencing for diagnosing IFD.ContentsFungal biomarkers are useful adjuncts as screening and diagnostic tools for IFD and are much more suited for ‘ruling out’ rather than ‘ruling in’ disease. GM, NAA tests are promising biomarkers for screening of invasive Aspergillosis in high risk asymptomatic patients who are not on antifungal therapy and for diagnosis of breakthrough infections in symptomatic patients. 1–3, β D glucan has limitations both as a ‘rule in’ and ‘rule out’ test and is useful in only specific clinical settings. Two consecutive positive 1-3-βDG tests or combined positivity with GM increases its specificity. Mn/antiMn, T2Candida nano diagnostic panel are promising candidates for diagnosing invasive candidiasis. Combining two or more biomarkers improves the sensitivity for prompt initiation of antifungal therapy and the negative predictive value for suspension of empirical treatment.Serum CrAg test is a good ‘rule in’ rather than a ‘rule out’ test in immunocompetent patients but has good diagnostic accuracy in immunocompromised patients. Detection of single nucleotide polymorphisms by next generation sequencing is useful for fungal characterization and identification of host determinants responsible for increased susceptibility to fungal infections but is still in experimental stages. 相似文献
10.